Immunoglobulin G1-kappa

Immunoglobulin G1-kappa Uses, Dosage, Side Effects, Food Interaction and all others data.

Immunoglobulin G1-kappa is under investigation in clinical trial NCT02540356 (Phase 1/2a Two-arm Dose-escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian Cancer).

Trade Name Immunoglobulin G1-kappa
Generic Imalumab
Imalumab Other Names Imalumab, Immunoglobulin g1-kappa, anti-(homo sapiens mif (macrophage migration inhibitory factor, glycosylation-inhibiting factor, glif, gif)), homo sapiens monoclonal antibody
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Immunoglobulin G1-kappa
Immunoglobulin G1-kappa

Innovators Monograph

You find simplified version here Immunoglobulin G1-kappa

*** Taking medicines without doctor's advice can cause long-term problems.
Share